Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Company

Vergent Bioscience

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · PHASE 3 TRIAL

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

ClinicalTrials.gov

This is a Phase 3 registry record with no posted results; the study is actively recruiting and design details do not yet support efficacy or safety claims.

PreliminaryLung Metastases Vergent Bioscience NCT07499674

Reported

Planned enrollment132

Minimum evaluable participants (i…115

Control group (abenacianine, no N…12

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support